Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268845
Max Phase: Preclinical
Molecular Formula: C45H64N10O8
Molecular Weight: 873.07
Associated Items:
ID: ALA5268845
Max Phase: Preclinical
Molecular Formula: C45H64N10O8
Molecular Weight: 873.07
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)N[C@@H](Cc2ccccc2)C(=O)O)Cc2cn(c3ccccc23)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C45H64N10O8/c1-7-27(6)37-41(59)49-31(17-13-19-48-44(46)47)38(56)51-34(21-26(4)5)42(60)55-24-29(30-16-11-12-18-36(30)55)23-33(40(58)54-37)50-39(57)32(20-25(2)3)52-45(63)53-35(43(61)62)22-28-14-9-8-10-15-28/h8-12,14-16,18,24-27,31-35,37H,7,13,17,19-23H2,1-6H3,(H,49,59)(H,50,57)(H,51,56)(H,54,58)(H,61,62)(H4,46,47,48)(H2,52,53,63)/t27-,31-,32-,33-,34-,35-,37-/m0/s1
Standard InChI Key: HXPTZHQTKSTIMK-OQYWAUBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 873.07 | Molecular Weight (Monoisotopic): 872.4909 | AlogP: 2.54 | #Rotatable Bonds: 17 |
Polar Surface Area: 278.73 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.95 | CX Basic pKa: 12.20 | CX LogP: 1.27 | CX LogD: 1.27 |
Aromatic Rings: 3 | Heavy Atoms: 63 | QED Weighted: 0.05 | Np Likeness Score: 0.43 |
1. Lu S, Zhang Z, Sharma AR, Nakajima-Shimada J, Harunari E, Oku N, Trianto A, Igarashi Y.. (2023) Bulbiferamide, an Antitrypanosomal Hexapeptide Cyclized via an N-Acylindole Linkage from a Marine Obligate Microbulbifer., 86 (4): [PMID:36843290] [10.1021/acs.jnatprod.2c01083] |
Source(1):